Controversies in oncology: surgery for small cell lung cancer? It's time to rethink the case

[Implementation of a national lung cancer screening in Austria : Position paper of the Austrian Radiological Society (ÖRG), the Austrian Society of Pneumology (ÖGP), the Austrian Society of General Practice and Family Medicine (ÖGAM) and the Austrian Society of Thoracic Surgery (ÖGTC)].

Wiener klinische Wochenschrift·2026

Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

Cancers·2026

Current advances in extended resections for non-small cell lung cancer-a narrative review.

Translational lung cancer research·2026

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Diagnostics (Basel, Switzerland)·2026

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Cancer letters·2026

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Antioxidants (Basel, Switzerland)·2026

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer.

ESMO open·2026

A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas.

ESMO open·2026

"Our patients deserve better"-roadblocks to optimal care in biliary malignancies.

ESMO open·2026

First-line toripalimab in combination with platinum-doublet chemotherapy for advanced B3 thymoma and thymic carcinoma: an open-label prospective phase Ⅱ trial.

ESMO open·2026

Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial.

ESMO open·2026

Indirect comparison of reconstructed individual patient data from KEYNOTE-905/EV-303 and PURE-01: complementary analyses for interpreting event-free survival in muscle-invasive bladder cancer.

ESMO open·2026

Harnessing the ion transportome to treat cancer.

The Journal of physiology·2026

Hesperidin Attenuates Vincristine-Induced Nephrotoxicity via Nrf2/HO-1 and PI3K/Akt/mTOR Signaling.

Journal of biochemical and molecular toxicology·2026

Pharmacological Modulation of Catecholaminergic Brain Injury by Dapagliflozin and Its Nanovesicular Formulation in an Isoproterenol Model.

Journal of biochemical and molecular toxicology·2026

Mapping care interventions for people living with motor neurone disease: a living evidence and gap map.

Neurodegenerative disease management·2026

Effectiveness of a Specialized Outpatient Clinic on Bone Metastasis for Spine Surgeons Based on a Long-Term Follow-Up Evaluation.

Spine surgery and related research·2026

Clodronate and trehalose exhibit a paradoxical antagonistic interaction that suppresses proliferation of canine mammary tumour cells.

Veterinary and animal science·2026

Related Experiment Videos

Controversies in oncology: surgery for small cell lung cancer? It's time to rethink the case

Related Concept Videos

[Implementation of a national lung cancer screening in Austria : Position paper of the Austrian Radiological Society (ÖRG), the Austrian Society of Pneumology (ÖGP), the Austrian Society of General Practice and Family Medicine (ÖGAM) and the Austrian Society of Thoracic Surgery (ÖGTC)].

Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

Current advances in extended resections for non-small cell lung cancer-a narrative review.

MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancer.

A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas.

"Our patients deserve better"-roadblocks to optimal care in biliary malignancies.

First-line toripalimab in combination with platinum-doublet chemotherapy for advanced B3 thymoma and thymic carcinoma: an open-label prospective phase Ⅱ trial.

Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial.

Indirect comparison of reconstructed individual patient data from KEYNOTE-905/EV-303 and PURE-01: complementary analyses for interpreting event-free survival in muscle-invasive bladder cancer.

Harnessing the ion transportome to treat cancer.

Hesperidin Attenuates Vincristine-Induced Nephrotoxicity via Nrf2/HO-1 and PI3K/Akt/mTOR Signaling.

Pharmacological Modulation of Catecholaminergic Brain Injury by Dapagliflozin and Its Nanovesicular Formulation in an Isoproterenol Model.

Mapping care interventions for people living with motor neurone disease: a living evidence and gap map.

Effectiveness of a Specialized Outpatient Clinic on Bone Metastasis for Spine Surgeons Based on a Long-Term Follow-Up Evaluation.

Clodronate and trehalose exhibit a paradoxical antagonistic interaction that suppresses proliferation of canine mammary tumour cells.

Related Experiment Videos

Controversies in oncology: surgery for small cell lung cancer? It's time to rethink the case

Related Concept Videos

Related Articles